Design Therapeutics, Inc.DSGNNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+5.8%
5Y CAGR+56.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.8%/yr
Annual compound
5Y CAGR
+56.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
9.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $79.47M | +28.6% |
| 2024 | $61.79M | -20.4% |
| 2023 | $77.65M | +15.7% |
| 2022 | $67.13M | +87.3% |
| 2021 | $35.83M | +319.0% |
| 2020 | $8.55M | +348.2% |
| 2019 | $1.91M | - |